Skip to main content

Services

We offer multiple services in our holding structure

As holding, BioNTech SE encompasses several subsidiaries focused on specific aspects of the BioNTech business. These includes our therapeutic development units as well as certain subsidiaries that also provide external service offerings

Services:
  • JPT Peptide Technologies GmbH
    Our fully-owned subsidiary in Berlin provides peptide manufacturing services.
    For more information, please contact info@jpt.com.
  • BioNTech Innovative Manufacturing Service GmbH (IMFS)
    BioNTech Innovative Manufacturing Service GmbH (BIMFS) is a fully-owned manufacturing subsidiary in Idar-Oberstein that offers leading GMP manufacturing services for mRNA and cell and gene therapies.
    For more information, please contact: info-imfs@biontech.de.
  • BioNTech Small Molecules GmbH
    BioNTech Small Molecules GmbH offers fully-integrated research services, covering all scientific disciplines for small molecule drug discovery: from hit identification via in silico screening through hit-to-lead and lead optimization to preclinical development.
    For more information, please contact info@biontech.de.
  • BioNTech Diagnostics GmbH
    BioNTech Diagnostics GmbH develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products through selected partners. The first commercial diagnostic was launched in 2015.
    More information on MammaTyper can be found here.
Therapeutic Development:
BioNTech RNA Pharmaceuticals GmbH

BioNTech RNA Pharmaceuticals GmbH

BioNTech Small Molecules GmbH

BioNTech Cell & Gene Therapies GmbH

BioNTech Protein Therapeutics GmbH

BioNTech Protein Therapeutics GmbH

BioNTech Cell & Gene Therapies GmbH

BioNTech Small Molecules GmbH

BioNTech Research & Development, Inc.

BioNTech Research & Development, Inc.

We look forward to connecting with you